WS Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,885
| Closed | -$760K | – | 49 |
|
|
2023
Q4 | $760K | Hold |
15,885
| – | – | 0.05% | 40 |
|
|
2023
Q3 | $566K | Hold |
15,885
| – | – | 0.05% | 39 |
|
|
2023
Q2 | $733K | Hold |
15,885
| – | – | 0.06% | 38 |
|
|
2023
Q1 | $637K | Hold |
15,885
| – | – | 0.07% | 40 |
|
|
2022
Q4 | $736K | Hold |
15,885
| – | – | 0.06% | 40 |
|
|
2022
Q3 | $658K | Hold |
15,885
| – | – | 0.06% | 36 |
|
|
2022
Q2 | $948K | Hold |
15,885
| – | – | 0.08% | 41 |
|
|
2022
Q1 | $1.15M | Hold |
15,885
| – | – | 0.06% | 42 |
|
|
2021
Q4 | $1.34M | Hold |
15,885
| – | – | 0.11% | 40 |
|
|
2021
Q3 | $1.43M | Hold |
15,885
| – | – | 0.15% | 43 |
|
|
2021
Q2 | $1.52M | Hold |
15,885
| – | – | 0.15% | 52 |
|
|
2021
Q1 | $1.81M | Sell |
15,885
-807
| -5% | -$91.9K | 0.19% | 47 |
|
|
2020
Q4 | $2.31M | Hold |
16,692
| – | – | 0.24% | 33 |
|
|
2020
Q3 | $1.37M | Hold |
16,692
| – | – | 0.15% | 42 |
|
|
2020
Q2 | $1.31M | Sell |
16,692
-2,876
| -15% | -$225K | 0.16% | 39 |
|
|
2020
Q1 | $869K | Sell |
19,568
-985
| -5% | -$43.7K | 0.09% | 43 |
|
|
2019
Q4 | $878K | Hold |
20,553
| – | – | 0.08% | 46 |
|
|
2019
Q3 | $879K | Sell |
20,553
-2,271
| -10% | -$97.1K | 0.07% | 47 |
|
|
2019
Q2 | $1.45M | Sell |
22,824
-2,704
| -11% | -$172K | 0.09% | 47 |
|
|
2019
Q1 | $1.77M | Sell |
25,528
-3,444
| -12% | -$239K | 0.11% | 48 |
|
|
2018
Q4 | $1.26M | Sell |
28,972
-25,128
| -46% | -$1.09M | 0.06% | 62 |
|
|
2018
Q3 | $4.13M | Hold |
54,100
| – | – | 0.14% | 57 |
|
|
2018
Q2 | $4.16M | Buy |
+54,100
| New | +$4.16M | 0.12% | 55 |
|